# Calcitriol in the Treatment of Immunoglobulin A Nephropathy

> **NCT00862693** · PHASE4 · UNKNOWN · sponsor: **Peking University First Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Glomerulonephritis
- Autoimmune Diseases

## Interventions

- **DRUG:** Calcitriol

## Key facts

- **NCT ID:** NCT00862693
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2010-08
- **Final completion:** 2011-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862693, "Calcitriol in the Treatment of Immunoglobulin A Nephropathy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00862693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*